Related Experiment Video
Updated: Jun 25, 2026
06:08
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Understanding the relationship between age and thyroid cancer.
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and University of Wisconsin Paul P Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792, USA. mrh@medicine.wisc.edu
The Oncologist
|March 10, 2009
Summary
Age significantly impacts well-differentiated thyroid cancer prognosis, with distinct outcomes for patients under and over 45. This suggests age-dependent factors in the cancer or its treatment influence patient outcomes.
Area of Science:
- Endocrinology
- Oncology
- Cancer Research
Background:
- Age is a critical prognostic factor in well-differentiated thyroid cancer, differentiating outcomes even with similar disease extent.
- A notable disparity exists in prognosis between thyroid cancer patients younger than 45 and those older than 45.
Purpose of the Study:
- To investigate age-dependent characteristics of normal thyroid tissue and thyroid cancer.
- To explore potential theories linking advanced age to poorer thyroid cancer prognosis.
- To discuss age-tailored treatment strategies for thyroid cancer.
Main Methods:
- Review of existing literature on age as a prognostic factor in well-differentiated thyroid cancer.
- Analysis of age-related differences in thyroid cancer biology and treatment response.
- Exploration of theoretical models explaining the age-prognosis relationship.
Main Results:
- Age is a more significant prognostic indicator than initially recognized in well-differentiated thyroid cancer.
- Patients under 45 exhibit a different prognosis compared to older patients, irrespective of disease stage.
- The underlying reasons for age-dependent outcomes are not fully elucidated but point to intrinsic age-related factors.
Conclusions:
- The strong association between age and thyroid cancer outcome suggests intrinsic, age-dependent biological or treatment-related factors.
- Further research is needed to clarify the mechanisms behind age-related thyroid cancer prognosis.
- Personalized treatment approaches considering the patient's age at diagnosis are crucial for optimizing outcomes.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...